As his center wins comprehensive (again), Carlos Arteaga tells us how NCI’s standards have evolved

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

NCI has renewed the Harold C. Simmons Comprehensive Cancer Center’s comprehensive designation.

“I think this is special, because I think it is a marker of an evolution of the institution, which has always been a basic science powerhouse, and now is enhancing an increasingly outstanding enterprise in translational cancer research and cancer care, community outreach and engagement, and education and training in cancer,” Carlos L. Arteaga, director of the Simmons Cancer Center at UT Southwestern, said to The Cancer Letter.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Paul Goldberg
Editor & Publisher
Table of Contents

YOU MAY BE INTERESTED IN

Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. Their catchment areas are contiguous, their faculty and staff members collaborate often, and together their institutions embody the culture of NCI-designated cancer centers. 

In the first meeting of the National Cancer Advisory Board since the inauguration of President Donald Trump, NCI Principal Deputy Director Douglas R. Lowy addressed many of the burning questions the oncology field has for the institute. On indirect costs: NCI will continue to use previously negotiated and approved indirect cost rates, with the exception...

Paul Goldberg
Editor & Publisher

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login